Joung, Julia http://orcid.org/0000-0001-8133-8510
Kirchgatterer, Paul C.
Singh, Ankita
Cho, Jang H.
Nety, Suchita P. http://orcid.org/0000-0002-4201-1061
Larson, Rebecca C.
Macrae, Rhiannon K.
Deasy, Rebecca http://orcid.org/0000-0001-9143-6296
Tseng, Yuen-Yi
Maus, Marcela V. http://orcid.org/0000-0002-7578-0393
Zhang, Feng http://orcid.org/0000-0003-0178-7995
Article History
Received: 10 November 2021
Accepted: 25 February 2022
First Online: 25 March 2022
Competing interests
: J.J. and F.Z. are inventors listed on a U.S. Provisional Patent Application No. 63/196,520 entitled “Novel Targets for Enhancing Anti-Tumor Immunity”. F.Z. is a cofounder of Editas Medicine, Beam Therapeutics, Pairwise Plants, Arbor Biotechnologies, and Sherlock Biosciences. M.V.M. is on the scientific advisory board of Cabaletta Bio, Cellectis, In8bio, TCR2, and WindMIL, as well as the board of directors of 2Seventy Bio. M.V.M. is an equity holder of Century Therapeutics, Genocea, Oncternal, TCR2, and 2Seventy Bio. The remaining authors declare no competing interests.